Diffusing capacity of the lungs for carbon monoxide (DLCO) provides valuable insights into lung disease severity and progression. In clinical trials, DLCO assessment can also help identify drug-induced changes in pulmonary function and help establish the safety profiles of respiratory and non-respiratory therapies.
What is DLCO?
DLCO, also known as transfer factor for carbon monoxide (TLCO), measures the ability of the lungs to transfer gas from ambient air to circulating red blood cells. This endpoint is assessed through the uptake of carbon monoxide (CO), typically during a 10 second breath-hold of a dilute CO gas mixture. Carbon monoxide is used as a surrogate marker for oxygen as it has a higher affinity for hemoglobin (up to 250X) and its uptake is less impacted by bodily oxygen utilization.
For which indications is DLCO assessed?
Identification of normal or aberrant DLCO is an important component in the evaluation of various respiratory diseases:
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis (CF)
- Interstitial Lung Disease (ILD)
- Pulmonary vascular disease Neuromuscular disorders
ndd® EasyOne Pro
ndd® EasyOne Pro
Standardized DLCO device solution
Clario offers standardized, centralized DLCO analysis with the ndd® EasyOne Pro, a high-quality, easy-to-use, lightweight device capable of providing DLCO results in three minutes via single breath diffusion. The EasyOne Pro is pre-calibrated and requires no warm-up time, leveraging ndd’s proprietary technologies.
Complete, high-resolution digital DLCO and spirometry curves can be easily uploaded directly into Clario’s EXPERT® database. Clario over-reads data for consistency and plausibility, alerting the sponsor to potential deviations or sites in need of retraining, ultimately helping sponsors generate the best-possible data.
- Minimizes device, site and gas variability
- Improved data resolutions and more accurate readings
- Consistent data labeling
- Customized workflow captures only timepoints and PPIs dictated by protocol
- Centralization can reduce variability by up to 50%
- All gas tanks, regulators and carts are included and sourced from vetted suppliers
Learn more about the ndd EasyOne Pro system
Non-standard, paper-based solution
While losing the benefit of standardized equipment, sponsors interested in using existing equipment at specialized sites can utilize Clario Link, our flexible paper-based solution. A combination of existing site equipment and Clario-provided rental equipment can be used, and digitized paper readings from all sites are uploaded to the Clario EXPERT® portal for centralized review and data reconciliation.
- Low cost
- Rent devices only when needed
- Compatible with most existing DLCO capture devices
- Same great training, review, analysis and reporting
Site-Based Spirometry (FEV1, FVC, PEF, etc.)
Centralized, on-site pulmonary function testing for clinical trials.
Home & Hybrid DCT Spirometry
Remote spirometry testing for respiratory clinical trials.
Cough and Lung Sounds
Assessment of cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.
Talk to a specialist
Our team of experts is available to address questions you may have about our integrated respiratory solutions. Submit your contact information and we’ll be in touch shortly.